Clinical Trial Update: Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports on a phase 2 trial evaluating simvastatin with gemcitabine in pancreatic cancer that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Samsung Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED